Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001698262-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
16
Total Shares
592,048
Total Value
$17,234,447.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 39,000 | $25.25 | $984,750.00 | 154,745 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 39,650 | $17.96 | $712,114.00 | 194,395 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Sale | 63,907 | $61.99 | $3,961,850.56 | 130,488 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Sale | 29,021 | $62.66 | $1,818,316.56 | 101,467 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Sale | 3,000 | $63.65 | $190,952.40 | 98,467 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 15, 2026 | Sale | 270 | $65.31 | $17,633.70 | 98,197 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 350 | $17.96 | $6,286.00 | 98,547 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 55,000 | $15.46 | $850,300.00 | 153,547 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 57,500 | $26.88 | $1,545,600.00 | 211,047 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 16, 2026 | Sale | 65,104 | $63.12 | $4,109,397.03 | 145,943 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Sep 16, 2026 | Sale | 47,746 | $63.61 | $3,037,247.20 | 98,197 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 39,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 39,650 | $0.00 | $0.00 | 350 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 350 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 55,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 57,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |